EPAS1 and neoplasm: Thereby, it is supposed to mediate a switch from HIF-1α to HIF-2α-dependent transcription during tumor hypoxia by selectively degrading HIF-1α and promoting HIF-2α transactivation without affecting HIF-2α levels [101,102].